Does Dr. MOSHE LEVY have financial conflicts of interest?

Dr. MOSHE LEVY (MD) has received a total of $3,752,167 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $3,642,987 in personal promotional payouts (consulting, meals, travel) and $109,179 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOSHE LEVY?

According to CMS Open Payments data, Dr. MOSHE LEVY received funding from SEAGEN ($973,515), E.R. SQUIBB & SONS, L.L.C ($312,521), and INCYTE CORPORATION ($288,238).

Does Dr. MOSHE LEVY receive research grants or speaking fees?

Dr. MOSHE LEVY has received $3,642,987 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $109,179 in clinical research grants.

DR. MOSHE LEVY

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: DALLAS, TX 75246

NPI Number: 1518059807

LIFETIME INDUSTRY VALUE

$3,752,167

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. LEVY is a verified Internal Medicine, Medical Oncology practitioner based in DALLAS, TX.

Between 2021 and 2025, Dr. LEVY had an overall industry promotional and research financial footprint of $3,752,167 as recorded in the federal CMS Open Payments database.

$3,642,987 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$109,179 was allocated to sponsored clinical trials and medical research activities.

Dr. LEVY's primary funding source is SEAGEN, which accounts for $973,515 (representing 25.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SEAGEN

Rank 1

$973,515

25.9%

E.R. SQUIBB & SONS, L.L.C

Rank 2

$312,521

8.3%

INCYTE CORPORATION

Rank 3

$288,238

7.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.